# Cognitive Changes Associated With Breast Cancer Treatment

> **NCT00550134** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 53 (actual)

## Conditions studied

- Breast Cancer
- Cognitive Side Effects of Cancer Treatments
- Stage I, II and III A Breast Cancer

## Interventions

- **BEHAVIORAL:** Questionnaires, MRI, Comet assay and Cell senescence
- **BEHAVIORAL:** Questionnaires, MRI, Comet assay and Cell senescence
- **BEHAVIORAL:** Questionnaires, MRI, Comet assay and Cell senescence

## Key facts

- **NCT ID:** NCT00550134
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-24
- **Primary completion:** 2021-12-28
- **Final completion:** 2021-12-28
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2021-12-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550134, "Cognitive Changes Associated With Breast Cancer Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00550134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*